The Danish pharmaceutical company Novo Nordisk, which produces the anti-obesity drug “Ozempic”, has announced the reduction of 9 thousand of its employees, which is 11% of its staff. About 5 thousand people are planned to be dismissed directly in Denmark, – reports Logos Press with reference to RBC.
